


The Fund aims to achieve long term capital growth.
| Name | % Net Assets | 
|---|---|
| General Electric Co. | 2.7% | 
| Bank of America Corp. | 2.7% | 
| Sanofi-Synthelabo | 2.7% | 
| Pfizer Inc. | 2.3% | 
| France Telecom | 1.9% | 
| J.P. Morgan Chase & Co. | 1.8% | 
| Occidental Petroleum Corp. | 1.8% | 
| Microsoft Corp. | 1.8% | 
| Credit Suisse Group | 1.7% | 
| OCCIDENTAL PETROLEUM CORP | 1.7% | 
| Key | % Net Assets | 
|---|---|
| 2.7% | |
| 2.7% | |
| 2.7% | |
| 2.3% | |
| 89.6% | 
| Date | 20-Aug-2025 | 
|---|---|
| NAV | 1,740.90p | 
| Currency | GBP | 
| Change | -10.51p | 
| % | -0.60% | 
| YTD change | 164.43p | 
| YTD % | 10.43% | 
| Fund Inception | 14/02/1994 | 
|---|---|
| Fund Manager | Mark Breedon / James Hand / Sandi Merwitz | 
| TER | 1.62 (31-Dec-2011) | 
| Minimum Investment | |
|---|---|
| Initial | £1000 | 
| Additional | £100 | 
| Savings | £100 | 
| Charges | |
|---|---|
| Initial | 4.50% | 
| Annual Mang't | 1.50% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| Standard deviation | 0.02 | 
| Sharpe ratio | 0.02 | 
You are here: research